Brain Tumor Res Treat.  2024 Jan;12(1):80-86. 10.14791/btrt.2023.0047.

Central Nervous System Dissemination of Solitary Sporadic Supratentorial Hemangioblastoma: A Case Report and Literature Review

Affiliations
  • 1Departments of 1 Neurosurgery and 2 Pathology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea

Abstract

We report a patient with whole neuroaxis dissemination of a sporadic supratentorial hemangioblastoma (HB) for more than 15 years. A 68-year-old female patient presented with severe radiating pain in the right leg. Gadolinium-enhanced lumbar spine MRI showed an intradural mass (2.5 cm in diameter) at the L4 level. The patient had been severely disabled for 22 years after a previous intraventricular brain tumor resection. At that time, the diagnosis was angioblastic meningioma, which was thought to be incorrect. At 14 years after the brain surgery, gamma knife radiosurgery was performed three times for newly developed or recurred supratentorial and infratentorial tumors in the cerebrospinal fluid pathway. The patient underwent lumbar spinal surgery, and a gross total removal of the mass was performed, which confirmed the histopathological diagnosis of HB. We reexamined the old histopathological specimen of the intraventricular tumor from 20 years ago and changed the diagnosis from angioblastic meningioma to supratentorial HB. Six months after spinal surgery, the patient underwent a second spinal surgery and brain surgery, and the histopathological diagnosis was HB following both surgeries, which was the same following the first spinal surgery. Here, we report a sporadic supratentorial HB patient who showed cranial and spinal disseminations for more than two decades along with a literature review

Keyword

Dissemination; Hemangioblastoma; Spine; Surgery; Magnetic resonance image; Recurrence

Figure

  • Fig. 1 Gadolinium (Gd)-enhanced sagittal lumbar spine MRI (July 2022) (A) of an intradural mass (2.5 cm in diameter) at the L4 level with well-homogeneous enhancement, which occupied the whole spinal canal at this level. Gd-enhanced whole-spine MRI of other masses at the cervical and thoracic spines (B). The tumor showed histological features with irregularly formed vessels interspersed with large stromal cells (C; H&E, ×100). The tumor cells were slightly positive for alpha-inhibin (D; immunohistochemistry, ×200) but strongly positive for EGFR (E; ×200).

  • Fig. 2 Gadolinium-enhanced axial brain MRI (December 2000) of an intraventricular mass (4 cm in diameter) at the third and lateral ventricles.

  • Fig. 3 Gadolinium-enhanced axial brain MRIs (April 2014) of the tumors in the cerebellomedullary cistern (A) and fourth ventricle (B).

  • Fig. 4 The tumor exhibited irregularly dilated blood vessels and extensive hemorrhage at low magnification (A; H&E staining, original magnification ×40). At high magnification, the tumor had vacuolated stromal cells characterized by large hyperchromatic nuclei and an eosinophilic foamy cytoplasm (B; H&E, ×200).

  • Fig. 5 Gadolinium (Gd)-enhanced sagittal spine MRI (January 2023) of a progressed 2 cm-sized vividly enhancing intramedullary mass at the T9 level (A), and Gd-enhanced axial brain MRI (May 2023) of the tumor in the right cerebellopontine angle (B). Histopathologically, the second recurrent brain tumor was composed of plump tumor cells characterized by a clear cytoplasm (C; H&E, ×100) with immunopositivity for alpha-inhibin (D; ×200) and EGFR (E; ×200).


Reference

1. Bains SJ, Niehusmann PF, Meling TR, Saxhaug C, Zuchner M, Brandal P. Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease-a case report and literature review. Acta Neurochir (Wien). 2019; 161:343–349. PMID: 30652202.
Article
2. Chung SY, Jeun SS, Park JH. Disseminated hemangioblastoma of the central nervous system without von Hippel-Lindau disease. Brain Tumor Res Treat. 2014; 2:96–101. PMID: 25408933.
Article
3. Kim HR, Suh YL, Kim JW, Lee JI. Disseminated hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report. J Korean Med Sci. 2009; 24:755–759. PMID: 19654966.
Article
4. Amelot A, Bouazza S, Polivka M, George B, Bresson D. Sporadically second localization of cerebellar hemangioblastoma in sella turcica mimicking a meningioma with no associated von Hippel-Lindau disease. Br J Neurosurg. 2015; 29:589–591. PMID: 25817084.
Article
5. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995; 194:629–642. PMID: 7862955.
Article
6. Girmens JF, Erginay A, Massin P, Scigalla P, Gaudric A, Richard S. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol. 2003; 136:194–196. PMID: 12834696.
Article
7. Hasselblatt M, Jeibmann A, Gerss J, Behrens C, Rama B, Wassmann H, et al. Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases. Neuropathol Appl Neurobiol. 2005; 31:618–622. PMID: 16281910.
Article
8. Kato M, Ohe N, Okumura A, Shinoda J, Nomura A, Shuin T, et al. Hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report. J Neurooncol. 2005; 72:267–270. PMID: 15937651.
Article
9. Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, et al. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res. 1998; 58:504–508. PMID: 9458097.
10. Omar AI. Bevacizumab for the treatment of surgically unresectable cervical cord hemangioblastoma: a case report. J Med Case Rep. 2012; 6:238. PMID: 22883663.
Article
11. Raghavan R, Krumerman J, Rushing EJ, White CL 3rd, Chason DP, Watson ML, et al. Recurrent (nonfamilial) hemangioblastomas involving spinal nerve roots: case report. Neurosurgery. 2000; 47:1443–1448. PMID: 11126917.
Article
12. Ramachandran R, Lee HS, Matthews B, Shatzel A, Tihan T. Intradural extramedullary leptomeningeal hemangioblastomatosis and paraneoplastic limbic encephalitis diagnosed at autopsy: an unlikely pair. Arch Pathol Lab Med. 2008; 132:104–108. PMID: 18181660.
Article
13. Takayanagi S, Mukasa A, Tanaka S, Nomura M, Omata M, Yanagisawa S, et al. Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Neuro Oncol. 2017; 19:1228–1236. PMID: 28379443.
Article
14. Tohyama T, Kubo O, Kusano R, Miura N, Himuro H. [A case of hemangioblastoma with subarachnoid dissemination]. No Shinkei Geka. 1990; 18:83–88. Japanese. PMID: 2304611.
15. Bakshi R, Mechtler LL, Patel MJ, Lindsay BD, Messinger S, Gibbons KJ. Spinal leptomeningeal hemangioblastomatosis in von Hippel-Lindau disease: magnetic resonance and pathological findings. J Neuroimaging. 1997; 7:242–244. PMID: 9344008.
Article
16. Mohan J, Brownell B, Oppenheimer DR. Malignant spread of haemangioblastoma: report on two cases. J Neurol Neurosurg Psychiatry. 1976; 39:515–525. PMID: 1084914.
Article
17. Reyns N, Assaker R, Louis E, Lejeune JP. Leptomeningeal hemangioblastomatosis in a case of von Hippel-Lindau disease: case report. Neurosurgery. 2003; 52:1212–1215. discussion 1215-6. PMID: 12699568.
Article
18. Weil RJ, Vortmeyer AO, Zhuang Z, Pack SD, Theodore N, Erickson RK, et al. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases. J Neurosurg. 2002; 96:775–787. PMID: 11990821.
Article
19. Hanse MC, Vincent A, van den Bent MJ. Hemangioblastomatosis in a patient with von Hippel-Lindau disease. J Neurooncol. 2007; 82:163–164. PMID: 17256106.
Article
20. Akimoto J, Fukuhara H, Suda T, Nagai K, Hashimoto R, Michihiro K. Disseminated cerebellar hemangioblastoma in two patients without von Hippel-Lindau disease. Surg Neurol Int. 2014; 5:145. PMID: 25324974.
Article
21. Seystahl K, Weller M, Bozinov O, Reimann R, Rushing E. Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastoma. Oncol Res Treat. 2014; 37:209–212. PMID: 24732646.
Article
22. Kim H, Park IS, Jo KW. Meningeal supratentorial hemangioblastoma in a patient with von Hippel-Lindau disease mimicking angioblastic menigioma. J Korean Neurosurg Soc. 2013; 54:415–419. PMID: 24379949.
Article
23. Crivelli G, Dario A, Cerati M, Dorizzi A. Solid supratentorial haemangioblastoma. Case report. J Neurosurg Sci. 1992; 36:161–166. PMID: 1484303.
Full Text Links
  • BTRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr